Immucor Accepts $2 Billion Private Equity Buyout, But Open To Richer Offer
This article was originally published in The Gray Sheet
Executive Summary
Blood transfusion testing product maker Immucor will gain added financial resources for future growth following investment firm TPG Capital’s purchase of the company for $1.97 billion, the firm announced July 5.
You may also be interested in...
People In Brief
Accuray, Svelte Medical Systems and Sonoma Orthopedics get new CEOs, and more personnel news from device companies.
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2011
Medical device companies raised a total of $906 million in Q3, while in vitro diagnostic/research developers took in $72 million. The top M&As in each segment were private buyouts of public companies: Kinetic Concepts for $6.3 billion and Immucor for $1.9 billion.
Kinetic Concepts To Go Private Via $6.3 Billion Buyout
Kinetic Concepts’ acceptance of a $6.3 billion private equity buyout deal with a consortium of investors, announced July 13, could mark the opening salvo of a bidding war for the wound care device maker.